Amprius Technologies (NYSE:AMPX) CTO Sells $5,933,637.08 in Stock

Key Points

• Amprius CTO Constantin Ionel Stefan sold 492,827 shares on Jan. 22 at an average $12.04 for $5,933,637.08, leaving him with 748,696 shares and representing a 39.7% decrease in his ownership stake.
• Including other recent trades from Nov.–Jan., Stefan has sold roughly 790,986 shares for about $9.17 million, indicating sustained insider selling activity over the past months.
• Shares of AMPX recently traded at $11.17 (12‑month range $1.70–$16.03) with a market cap of ~$1.46B, and analysts hold a consensus "Moderate Buy" with an average target of $16.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) CTO Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total value of $5,933,637.08. Following the transaction, the chief technology officer owned 748,696 shares of the company's stock, valued at $9,014,299.84. This represents a 39.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Constantin Ionel Stefan also recently made the following trade(s):

• On Friday, January 23rd, Constantin Ionel Stefan sold 1,600 shares of Amprius Technologies stock. The stock was sold at an average price of $12.00, for a total value of $19,200.00.
• On Wednesday, January 21st, Constantin Ionel Stefan sold 73,280 shares of Amprius Technologies stock. The shares were sold at an average price of $12.00, for a total value of $879,360.00.
• On Thursday, December 11th, Constantin Ionel Stefan sold 198,255 shares of Amprius Technologies stock. The shares were sold at an average price of $10.51, for a total value of $2,083,660.05.
• On Friday, November 21st, Constantin Ionel Stefan sold 25,024 shares of Amprius Technologies stock. The shares were sold at an average price of $10.08, for a total transaction of $252,241.92.

Amprius Technologies Price Performance

NYSE:AMPX traded down $0.78 on Friday, reaching $11.17. The stock had a trading volume of 7,143,717 shares, compared to its average volume of 7,991,321. Amprius Technologies, Inc. has a 12-month low of $1.70 and a 12-month high of $16.03. The company has a market cap of $1.46 billion, a price-to-earnings ratio of -42.97 and a beta of 3.04. The firm's fifty day moving average is $10.11 and its two-hundred day moving average is $9.77.

Amprius Technologies (NYSE:AMPX - Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.03. The business had revenue of $21.43 million during the quarter, compared to the consensus estimate of $16.45 million. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%. As a group, research analysts forecast that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AMPX has been the topic of a number of recent analyst reports. Cantor Fitzgerald increased their price target on Amprius Technologies from $12.00 to $16.00 and gave the stock an "overweight" rating in a research note on Friday, November 7th. Northland Securities set a $20.00 price target on Amprius Technologies in a research note on Tuesday, October 7th. Roth Mkm set a $14.00 price target on Amprius Technologies and gave the company a "buy" rating in a report on Wednesday, October 22nd. Weiss Ratings reiterated a "sell (e+)" rating on shares of Amprius Technologies in a report on Wednesday. Finally, Oppenheimer reissued an "outperform" rating and issued a $17.00 target price on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Six equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Amprius Technologies has an average rating of "Moderate Buy" and an average target price of $16.00.

Institutional Investors Weigh In On Amprius Technologies

Several institutional investors have recently bought and sold shares of the business. Quarry LP acquired a new stake in Amprius Technologies during the 3rd quarter valued at approximately $42,000. Jones Financial Companies Lllp boosted its stake in shares of Amprius Technologies by 353.2% during the 3rd quarter. Jones Financial Companies Lllp now owns 4,532 shares of the company's stock valued at $50,000 after buying an additional 3,532 shares during the last quarter. Parallel Advisors LLC acquired a new stake in shares of Amprius Technologies during the third quarter worth approximately $54,000. Geneos Wealth Management Inc. acquired a new stake in shares of Amprius Technologies during the third quarter worth approximately $74,000. Finally, Ameritas Investment Partners Inc. increased its stake in shares of Amprius Technologies by 2,043.2% in the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company's stock worth $40,000 after buying an additional 9,072 shares during the last quarter. 5.04% of the stock is currently owned by hedge funds and other institutional investors.

Amprius Technologies Company Profile

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.